Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT01909453 |
Title | Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma (COLUMBUS) |
Acronym | COLUMBUS |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | Yes |
Sponsors | Pfizer |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | AUS |